Today: 20 May 2026
Charles Schwab Stock Surges on Blowout Q3 Results, Analysts Eye More Upside
16 October 2025
2 mins read

Charles Schwab Stock Surges on Blowout Q3 Results, Analysts Eye More Upside

  • Q3 beat: Schwab reported record Q3 results on Oct. 16, with net revenue $6.14 billion (up 27% YoY) and adjusted EPS of $1.31 (versus ~$1.25 expected)chartmill.combenzinga.com. Net income was $2.36 billion (67% YoY growth)pressroom.aboutschwab.com. Management highlighted “client-driven growth” – total client assets hit $11.59 trillion (up 17% YoY) and core net new asset inflows were $137.5 billionpressroom.aboutschwab.com. New brokerage accounts topped 1 million (4th straight quarter)pressroom.aboutschwab.com.
  • Stock action: SCHW shares jumped after hours. The stock closed around $94 on Oct 15 and traded near $98 pre-market Oct 16 on the earnings beat. (One-year range is $65.88–$99.59.) Year-to-date the stock is well above last winter’s lows. Schwab also buys back stock ($20 billion authorized in July, $2.7 billion repurchased in Q3) and pays a $0.27 quarterly dividend ($1.08 annual, ~1.1% yield).
  • Analysts bullish: Before the report analysts had forecast ~$1.25 EPS on $6.02B revenuebenzinga.com, so the beat is significant. Major brokerages range from Neutral to Bullish: BMO Capital initiated an Outperform (Buy) on SCHW with a $110 12‑month targetbenzinga.com; Morgan Stanley reiterates an Overweight with ~$130 targetcapital.com; Barclays just hiked its target to $114capital.com. In short, price targets span roughly $110–$130capital.com, reflecting confidence in Schwab’s “bank-lite” model.
  • Peer and macro context: Competitors also posted strong results. Morgan Stanley’s wealth-management arm saw revenue of $8.2B (+13% YoY) in Q3reuters.com, and Interactive Brokers’ customer assets jumped 40% YoYtradingview.com. (Robinhood and other retail brokers have also rallied on booming trading activity.) At the same time, Fed Chair Powell’s Oct.14 speech spurred a bond rally – the 10-year U.S. yield fell toward ~4.02%reuters.com – a positive for banks/brokers. Charles Schwab strategist Collin Martin notes long-term yields “can still hold above 4%” even if the Fed cuts ratests2.tech, which could help Schwab’s net interest income.
  • Outlook: Analysts expect Schwab’s momentum to continue. Consensus Q4 2025 estimates are roughly $6.18B revenue and $1.28 EPS (versus Q4 2024’s $4.47B/$0.87). Schwab will hold a Fall Business Update on Oct.16 with CEO Rick Wurster, where management will discuss strategy. Industry forecasts remain broadly positive – for example, Wall Street firms have lifted their S&P 500 year-end targets (citing dovish policy and resilient earnings). If Schwab sustains its client growth and manages expenses, many experts say more upside is likely.

Schwab’s Q3 results illustrate a strong growth cycle: client assets are growing at a record pace and fee & trading revenues are robust. As Wurster put it, this reflects “strengthening organic growth trends” and “favorable macroeconomic tailwinds” powering another “quarter of record revenue and earnings per share”pressroom.aboutschwab.com. With analysts updating ratings upward (as detailed by Benzinga and Capital.com) and the stock trading near multi-year highs, the near-term outlook for SCHW is widely seen as upbeatbenzinga.comcapital.com. Investors will watch closely how this wealth-gathering momentum holds up if market conditions change.

Sources: Company filings and press release (Oct. 16 2025); MarketBeat and Benzinga earnings news; Capital.com and Reuters analysis; Nasdaq Earnings Calendar; Schwab investor communications.

Stock Market Today

  • Parabilis Plans IPO to Fund Phase 3 Trial for Tumor Drug Following Regeneron Deal
    May 20, 2026, 5:56 AM EDT. Parabilis Medicines, a Massachusetts biotech, is preparing for an initial public offering (IPO) to finance the phase 3 trial of its tumor drug zolucatetide, targeting rare desmoid tumors. The drug, which inhibits the Wnt/β-catenin pathway implicated in many cancers, recently received FDA fast-track status. Proceeds will also support phase 1 trials for additional cancers. Parabilis secured a $50 million upfront payment and a $75 million equity investment from Regeneron in a deal to explore Parabilis' helicon peptide platform. The firm boasts over $300 million in cash from prior funding rounds. CEO Mathai Mammen aims to grow Parabilis into a fully integrated research, development, manufacturing, and commercialization company, relying on partnerships to finance its ambitions.

Latest articles

San Antonio’s New Battery Bet Comes Just as CPS Outages Get Longer

San Antonio’s New Battery Bet Comes Just as CPS Outages Get Longer

20 May 2026
OCI Energy and CPS Energy have begun building a 120-megawatt battery storage facility in southeastern Bexar County, aiming for commercial operation in 2027. The project follows a rise in average outage duration for CPS Energy customers to 75.38 minutes in 2025. OCI will own the facility, with CPS holding operational control. ING is financing construction, and LG Energy Solution Vertech is supplying batteries.
Co-Diagnostics Jumps; $3 Million Deal Looms

Co-Diagnostics Jumps; $3 Million Deal Looms

20 May 2026
Co-Diagnostics announced a $3 million private placement after its stock surged 43.8% Tuesday, then fell 13.3% in after-hours trading. The company will sell 1.65 million shares or pre-funded warrants, plus warrants for up to 3.29 million more shares, nearly doubling its share count. The move follows its completion of a Bundibugyo virus assay as Ebola spreads in Congo and Uganda. Co-Diagnostics reported $8.2 million in cash at March 31.
Micron Stock Just Dodged the Nasdaq Selloff. A Samsung Strike Could Be Its Next Jolt

Micron Stock Just Dodged the Nasdaq Selloff. A Samsung Strike Could Be Its Next Jolt

20 May 2026
Micron Technology shares rose 2.5% Tuesday to $698.74, lifting its market value near $798 billion as the Nasdaq fell. Analysts cited tight memory supply and strong DRAM and NAND pricing. A planned strike by 48,000 Samsung workers Thursday could disrupt global memory supply, potentially raising prices. Micron recently sampled 256GB DDR5 server modules to partners.
MercadoLibre Stock Slides Amid Fintech Boom – Analysts Predict Big 2025 Comeback
Previous Story

MercadoLibre Stock Slides Amid Fintech Boom – Analysts Predict Big 2025 Comeback

NuScale Stock Skyrockets on Historic SMR Deal – Can GE Vernova Catch Up in the Nuclear Boom?
Next Story

NuScale Stock Skyrockets on Historic SMR Deal – Can GE Vernova Catch Up in the Nuclear Boom?

Go toTop